山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)05 粉末和颗粒 Powders and Granules

5. Powders and granules
5. Powders and Granules

Contents Powders l. Medicated powders l. Granules
Contents I. Powders II. Medicated powders III. Granules

I Powders a dry substance composed of finely divided particles A medicated powder intended for internal (i.e. oral powder) or external (i. e, topical powder)use
I. Powders ◼ A dry substance composed of finely divided particles ◼ A medicated powder intended for internal (i.e. oral powder) or external (i.e., topical powder) use

Powders are intimate mixtures of dry, finely divided drugs and lor chemicals that may be intended for internal or external use e.g. tablets, capsules, liquid dosage forms, ointments and creams
◼ Powders are intimate mixtures of dry, finely divided drugs and /or chemicals that may be intended for internal or external use. ◼ e.g. tablets, capsules, liquid dosage forms, ointments and creams

Granules are prepared agglomerates of powdered materials, may be used per se for the medicinal value of their content or they may be used for pharmaceutical purposes, as in making tablets
Granules are prepared agglomerates of powdered materials, may be used per se for the medicinal value of their content or they may be used for pharmaceutical purposes, as in making tablets

Before their use in the preparation of pharmaceutical products, solid materials first are characterized to determine their chemical and physical features including their morphology purity, solubility stability, particle sIze, a uniformity, compatibility with any other formulation components
Before their use in the preparation of pharmaceutical products, solid materials first are characterized to determine their chemical and physical features including their ◼ morphology, ◼ purity, ◼ solubility, ◼ stability, ◼ particle size, ◼ uniformity, ◼ compatibility with any other formulation components

Particle size and analysis Opening of standard sieves" Sieve nunber Sieve opening 9.5mm 234800o 5.6mm 4.75mm 2.36mm 200mm 26 850um 3 600Lm 40 425m 5O 300Lm 60 250m Zo 212以m sO 180,m 100 150,m 120 125Lm 200 75 Im 230 63 Hm 270 53 Im 325 45 Hm 400 38 Im Adapted from USP23-NFI8
一、Particle size and analysis

Powders of vegetable and animal drugs are officially defined as follows Very coarse(No 8): All particles pass through a No 8 sieve(2.36 mm) and not more than 20% through a No. 60 sieve (250m) Coarse(No 20): All particles pass through a No 20 sieve( 850 um)and not more than 40% through a No 60 sieve
Powders of vegetable and animal drugs are officially defined as follows: - Very coarse (No. 8): All particles pass through a No. 8 sieve (2.36 mm) and not more than 20% through a No. 60 sieve (250 m). - Coarse (No. 20): All particles pass through a No. 20 sieve (850 m) and not more than 40% through a No. 60 sieve

Moderately coarse(No 40 All particles pass through a No 40 sieve (425 um)and not more than 40% through a No 80 sieve(180 um) Fine(No. 60) All particles pass through a No 60 sieve (250 um) and not more than 40% through a No 100 sieve(150 um) Very fine(or a No. 80) I particles pass through a No 80 sieve There is no limit to greater fineness
- Moderately coarse (No. 40): All particles pass through a No. 40 sieve (425 m) and not more than 40% through a No.80 sieve (180 m). - Fine (No. 60): All particles pass through a No. 60 sieve (250 m) and not more than 40% through a No. 100 sieve (150 m). - Very fine (or a No. 80): All particles pass through a No. 80 sieve. There is no limit to greater fineness

The powder fineness for chemicals is defined as follows Course(or a No 20) powder-All particles pass through a No. 20 sieve and not more than 60% through a No. 40 sieve Moderately Course(or a No. 40) powder I particles pass through a No 40 sieve and not more than 60% through a No 60 sIeve
The powder fineness for chemicals is defined as follows ◼ Course (or a No. 20) powder-All particles pass through a No. 20 sieve and not more than 60% through a No. 40 sieve. ◼ Moderately Course (or a No. 40) powderAll particles pass through a No. 40 sieve and not more than 60% through a No. 60 sieve
按次数下载不扣除下载券;
注册用户24小时内重复下载只扣除一次;
顺序:VIP每日次数-->可用次数-->下载券;
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)01 Introduction to Drugs and Pharmacy 药物与药学导论.ppt
- 山东大学:《药物化学 Medicinal Chemistry》课程教学资源(PPT课件讲稿)Chapter 03 外周神经系统药物 Peripheral nervous system drugs.ppt
- 山东大学:《药物化学 Medicinal Chemistry》课程教学资源(PPT课件讲稿)Chapter 01 Introduction(主讲:马淑涛).ppt
- 山东大学:《药物化学 Medicinal Chemistry》课程教学资源(PPT课件讲稿)Chapter 12 维生素 Vitamins.ppt
- 山东大学:《药物化学 Medicinal Chemistry》课程教学资源(PPT课件讲稿)Chapter 13 New methods and techniques.ppt
- 复旦大学:《生物药剂学 Biopharmacy or Biopharmaceutics》教学课件_第六章 药物排泄 drug excretion 第一节 药物的肾排泄 第二节 药物的胆汁排泄 第三节 药物的其他排泄途径.pdf
- 复旦大学:《生物药剂学 Biopharmacy or Biopharmaceutics》教学课件_第五章 药物代谢(概述、药物代谢酶和代谢部位、反应的类型、影响因素、制剂设计).pdf
- 复旦大学:《生物药剂学 Biopharmacy or Biopharmaceutics》教学课件_第四章 药物的分布.pdf
- 复旦大学:《生物药剂学 Biopharmacy or Biopharmaceutics》教学课件_第三章 非口服给药的吸收.pdf
- 复旦大学:《生物药剂学 Biopharmacy or Biopharmaceutics》教学课件_第二章 口服药物的吸收(第四节 剂型因素对药物吸收的影响 第五节 口服药物吸收与制剂设计).pdf
- 复旦大学:《生物药剂学 Biopharmacy or Biopharmaceutics》教学课件_第二章 口服药物的吸收(第一节 药物的膜转运与胃肠道吸收 第二节 影响药物吸收的生理因素 第三节 影响药物吸收的物理化学因素).pdf
- 复旦大学:《生物药剂学 Biopharmacy or Biopharmaceutics》教学课件_第一章 生物药剂学概述(蒋晨).pdf
- 复旦大学:《生物药剂学 Biopharmacy or Biopharmaceutics》课程资源_教学大纲(蒋晨).pdf
- 复旦大学:《药物生命社会》教学课件(讲稿)抗生素与超级细菌.ppt
- 复旦大学:《药物生命社会》教学课件(讲稿)抗溃疡疗法的演变——交叉学科对药物治疗的贡献.pdf
- 复旦大学:《药物生命社会》教学课件(讲稿)酒与酒精滥用.pdf
- 复旦大学:《药物生命社会》教学课件(讲稿)药物与体育(兴奋剂Dope、刺激剂 stimulants, 41、麻醉止痛剂、合成类固醇、血液兴奋剂).pdf
- 复旦大学:《药物生命社会》教学课件(讲稿)药理学 pharmacology 药物的不良反应.pdf
- 复旦大学:《药物生命社会》教学课件(讲稿)新药发现的故事与启示.ppt
- 复旦大学:《药物生命社会》教学课件(讲稿)痛快与欣快——药物的个体效应与社会效应.pdf
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)03 Dosage Form Design:Pharmaceutic and Formulation Considerations.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)08 MODIFIED-RELEASE DOSAGE FORMS AND DRUG DELEVERY SYSTEMS.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)04 Dosage Form Design:Biopharmaceutic and Pharmacokinetic Considerations.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)09 Ointments, Creams and Gels 软膏、面霜和凝胶.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)11 Suppositories and Inserts 栓剂.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)12 Solutions.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)13 Disperse Systems(分散体系).ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)14 Parenterals 肠外注射.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)02 New Drug Development and Approval Process 新药开发和批准流程.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)07 Tablets 药片、片剂.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)10 Transdermal Drug Delivery Systems 经皮给药系统.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)16 Products of Biotechnology 生物技术(生物工程)产品.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)06 Capsules 胶囊.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)17 Novel Dosage Forms And Drug Delivery Technologies 新型剂型与药物传递技术.ppt
- 复旦大学:《临床药物治疗学 Clinical Pharmacotherapeutics》课程教学资源(教学大纲)Clinical Pharmacotherapeutics I.pdf
- 复旦大学:《临床药物治疗学 Clinical Pharmacotherapeutics》课程教学资源(教学大纲)Clinical Pharmacotherapeutics II.pdf
- 《医学与哲学》:论不合理用药及其表现、判断和处理(复旦大学:叶晓芬、蔡映云、吕迁洲).pdf
- 《临床药物治疗学 Clinical Pharmacotherapeutics》教学论文:以1例合并多种基础疾病的膜性肾病药物治疗为例分析药物治疗矛盾的处理.pdf
- 《临床药物治疗学 Clinical Pharmacotherapeutics》教学论文:临床药师对高血压患者的药学服务及其效果(复旦大学:李 静、吕迁洲).pdf
- 《中国临床药学杂志》:临床药师参与1例门静脉炎并发药物热的病例分析(复旦大学:张晓丹、王斌).pdf